Active Stocks to Watch: Bovie Medical Corporation (NYSEMKT:BVX), Frontier Communications Corporation (NASDAQ:FTR), A. Schulman, Inc. (NASDAQ:SHLM), Ironwood Pharmaceuticals (NASDAQ:IRWD), Talmer Bancorp (NASDAQ:TLMR)

Bovie Medical Corporation (NYSEMKT:BVX) belongs to Healthcare sector. Its net profit margin is -19.80% and weekly performance is -12.74%. On last trading day company shares ended up $2.26. Bovie Medical Corporation (NYSEMKT:BVX) distance from 50-day simple moving average (SMA50) is -17.05%. Zacks upgraded shares of Bovie Medical Corporation (NYSEMKT:BVX) from a hold rating to a buy rating in a research note issued to investors on Tuesday. The firm currently has $3.00 price target on the medical device company’s stock.

Frontier Communications Corporation (NASDAQ:FTR) shares decreased -1.00% in last trading session and ended the day at $4.93. FTR Gross Margin is 60.80% and its return on assets is 0.20%. Frontier Communications Corporation (NASDAQ:FTR) quarterly performance is -31.16%. Frontier Communications Corporation (NASDAQ:FTR) said that, it plans to release second-quarter 2015 results on Monday, August 3, 2015 before the market opens, and to host a conference call that morning at 8:30 A.M. Eastern Time

On 14 July, A. Schulman, Inc. (NASDAQ:SHLM) shares moved up 2.54% and was closed at $40.32. SHLM EPS growth in last 5 year was 33.20%. A. Schulman, Inc. (NASDAQ:SHLM) year to date (YTD) performance is 1.05%. On 6 July, A. Schulman, Inc. (NASDAQ:SHLM) said that, it has named Tony Daponte research and development director masterbatch for the Asia-Pacific region.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) ended the last trading day at $11.53. Company weekly volatility is calculated as 3.76% and price to cash ratio as 7.59. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) showed a weekly performance of -5.49%. On 8 July, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and AstraZeneca Pharmaceuticals Co., Ltd. announced that top-line data demonstrate linaclotide met all primary and secondary endpoints, covering multiple abdominal and constipation symptoms, in a Phase III clinical trial of adults with irritable bowel syndrome with constipation (IBS-C).

Talmer Bancorp, Inc. (NASDAQ:TLMR) shares moved up 1.18% in last trading session and ended the day at $17.96. TLMR return on assets is 1.70%. Talmer Bancorp, Inc. (NASDAQ:TLMR) quarterly performance is 12.39%.Talmer Bancorp, Inc. (NASDAQ:TLMR) said that, it will discuss second quarter 2015 earnings with the public on Thursday, July 30, at 10:00 A.M. ET via Talmer’s live quarterly earning conference webcast.

Leave a Reply

Your email address will not be published. Required fields are marked *